Frontiers in immunology · 2021
Case Report: Transformation From Cold to Hot Tumor in a Case of NSCLC Neoadjuvant Immunochemotherapy Pseudoprogression.
Клинический случайПоддержка исследования: вне правительства СШАСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jia Wenxiao, Zhu Hui, Gao Qianqian, Sun Jian, Tan Fujian, Liu Qun, Guo Hongbo, Yu Jinming
Аннотация
A 56-year-old male was diagnosed with right lung upper lobe squamous cancer with right hilar and mediastinum lymph node metastasis. After four cycles of neoadjuvant immunochemotherapy, reexamination by computed tomography showed progressive disease of the primary lesion. Then, the patient underwent a right lung upper lobectomy, and hilar and mediastinum lymph node dissection. Surgical pathology showed a partial response to immunochemotherapy. Single-cell RNA sequencing was used to characterize the infiltrating immune cell atlas after neoadjuvant immunochemotherapy; the most common infiltrating immune cell types were cytotoxic CD8+ T cells, monocyte-derived dendritic cells, and macrophages. Imaging mass cytometry revealed a transformation from cold to hot tumor after neoadjuvant immunochemotherapy. In this case study, we are the first to report a case of neoadjuvant immunochemotherapy pseudoprogression, proved by surgical pathology, single-cell RNA sequencing, and imaging mass cytometry. Both single-cell RNA sequencing and imaging mass cytometry revealed an activated immune microenvironment after neoadjuvant immunochemotherapy.
Предметные рубрики MeSH
Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsCD8-Positive T-LymphocytesCarcinoma, Non-Small-Cell LungChemotherapy, AdjuvantCisplatinDendritic CellsDeoxycytidineGene Expression ProfilingHumansImmune Checkpoint InhibitorsImmunohistochemistryLung NeoplasmsLymph Node ExcisionLymphatic MetastasisLymphocytes, Tumor-InfiltratingMaleMiddle AgedNeoadjuvant TherapyPneumonectomyRNA-SeqTranscriptomeTreatment OutcomeTumor BurdenTumor MicroenvironmentTumor-Associated MacrophagesGemcitabine